The safety and tolerability of an HIV-1 DNA prime–protein boost vaccine (DP6-001) in healthy adult volunteers-Reference-Cited by-同舟云学术

The safety and tolerability of an HIV-1 DNA prime–protein boost vaccine (DP6-001) in healthy adult volunteers

Published:2008-08 Issue:35 Volume:26 Page:4420-4424
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Kennedy Jeffrey S.,Co Mary,Green Sharone,Longtine Karen,Longtine Jaclyn,O’Neill Melissa A.,Adams Janice P.,Rothman Alan L.,Yu Qiao,Johnson-Leva Renita,Pal Ranajit,Wang Shixia,Lu Shan,Markham Phillip

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference35 articles.

1. Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime–protein boost HIV-1 vaccine in healthy human volunteers;Wang;Vaccine,2008

2. Immunization of rhesus macaques with a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine elicits protective antibody response against simian human immunodeficiency virus of R5 phenotype;Pal;Virology,2006

3. Definitive toxicology and biodistribution study of a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 (HIV-1) vaccine in rabbits;Pal;Vaccine,2006

4. New hope for an AIDS vaccine;Robinson;Nat Rev Immunol,2002

5. Vaccination of seronegative volunteers with a human immunodeficiency virus type 1 env/rev DNA vaccine induces antigen-specific proliferation and lymphocyte production of beta-chemokines;Boyer;J Infect Dis,2000

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and immunogenicity of a polyvalent DNA–protein HIV vaccine with matched Env immunogens delivered as a prime–boost regimen or coadministered in HIV-uninfected adults in the USA (HVTN 124): a phase 1, placebo-controlled, double-blind randomised controlled trial;The Lancet HIV;2024-05

2. A Predictive Model of Vaccine Reactogenicity Using Data from an In Vitro Human Innate Immunity Assay System;The Journal of Immunology;2024-01-26

3. Exploring the possible use of saponin adjuvants in COVID-19 vaccine;Human Vaccines & Immunotherapeutics;2020-12-01

4. Carbohydrate Immune Adjuvants in Subunit Vaccines;Pharmaceutics;2020-10-14

5. Construction of a novel tetravalent dengue vaccine with a Salmonella Typhimurium bacterial ghost and evaluation of its immunogenicity and protective efficacy using a murine model;Vaccine;2020-01